British Columbia Saves Over $700m From Biosimilar Switching
Biosimilar Switching Saved $226m Between 2023 And 2024 Alone
Executive Summary
Launched in 2019, the province’s biosimilar switching initiative has saved over $732m, which were reinvested into expanded coverage for drugs, and sparked a wave of similar projects in other Canadian regions.